Opyl Limited Company Description

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia.

The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions.

It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations.

The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019.

Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.

Opyl Limited

Country	Australia
Founded	1994
Industry	Health Information Services
Sector	Healthcare
CEO	Saurabh Jain

Contact Details

Address: 6 Middlemiss Street Milsons Point, 2061 Australia
Website	opyl.ai

Stock Details

Ticker Symbol	OPL
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000070856
SIC Code	1000

Key Executives

Name	Position
Saurabh Jain	Interim Chief Executive Officer and Executive Chairman
Mark Ziirsen	Chief Financial Officer
Damon Rasheed	Chief Technology Officer and Executive Director
Bernice Averion	Head of Marketing and Communications
Shane Lewis	Vice President of Sales and Partnerships
Scott Sorochak	Chief Revenue Officer
Jonathan Hart B.Com., L.L.B.	Company Secretary